收肌管阻滞对全膝关节置换术围手术期急性疼痛和功能的影响
该回顾性队列研究纳入2014年1月至2018年1月行单侧初次全膝关节置换术的患者,比较单次收肌管阻滞联合标准化多模式镇痛方案组(624例)与仅用多模式镇痛方案组(69例)。结果显示两组术后麻醉药用量无显著差异,收肌管阻滞组物理治疗行走距离更远、住院时间更短,但作者认为这些改善幅度可能不支持该干预的成本效益。
要点
- 收肌管阻滞未减少术后麻醉药用量(2.361 vs 2.097,P = .088)。
- 收肌管阻滞组物理治疗行走距离更远(75.8 vs 59.9英尺,P = .008)。
- 收肌管阻滞组总住院时间更短(34.8 vs 40.6小时,P = .01),术后第1天出院比例更高(83% vs 66.6%,P = .01)。
核心结论
- 收肌管阻滞未减少术后镇痛药物用量。
- 术后第1天物理治疗行走距离适度改善(16英尺)和住院时间缩短(术后第1天出院比例高16%)可能不支持该干预的成本效益。
研究设计与样本
- 回顾性队列研究,证据等级III级。
- 回顾性识别2014年1月至2018年1月连续行单侧初次全膝关节置换术的患者,比较单次收肌管阻滞联合标准化多模式镇痛方案组(624例,平均年龄64.5岁)与仅用多模式镇痛方案组(69例,平均年龄67.2岁)。
- 采用独立样本t检验比较两组,主要终点为住院时间、物理治疗行走距离和住院期间麻醉药用量。
主要发现
- 术后麻醉药用量两组无显著差异(2.361 vs 2.097,P = .088)。
- 收肌管阻滞组物理治疗行走距离显著更远(75.8 vs 59.9英尺,P = .008)。
- 收肌管阻滞组总住院时间更短(34.8 vs 40.6小时,P = .01),术后第1天出院比例更高(83% vs 66.6%,P = .01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multimodal pain management strategies are commonplace in perioperative management of total knee arthroplasty (TKA), although controversy remains regarding the role of adductor canal blocks (ACB) in this algorithm. The purpose of this study is to independently evaluate the effect of ACB on short-term postoperative outcomes including (1) length of stay (LOS), (2) postoperative narcotic utilization, and (3) function with physical therapy in the era of modern TKA. METHODS: We retrospectively identified a cohort of consecutive patients from January 2014 to January 2018 who had undergone unilateral primary TKA using a single-shot ACB in addition to a standardized multimodal pain regimen vs those who only received a multimodal pain regimen. These 2 groups were compared using independent sample t-tests with primary end points of interest being LOS, distance ambulated with therapy, and inpatient narcotic use. RESULTS: There were 624 patients in the ACB group, with a mean age of 64.5 years. The group without ACB consisted of 69 patients, with a mean age of 67.2 years. We observed no significant difference in narcotic utilization postoperatively (2.361 vs 2.097, P = .088). The ACB group ambulated significantly further with therapy (75.8 vs 59.9 ft, P = .008) and had a shorter LOS in both total hours and percentage of postoperative day 1 (%POD1) discharges (34.8 vs 40.6 hours, P = .01, 83% vs 66.6%, P = .01). CONCLUSION: ACB did not decrease postoperative pain medication utilization. The modest improvement in distance ambulated with therapy on POD1 (16 ft) and LOS (16% greater POD1 discharges) may not support the cost-effectiveness of this intervention. LEVEL OF EVIDENCE: III, Retrospective Cohort.
引用
- Rames RD, Barrack TN, Barrack RL, et al. Effect of Adductor Canal Block on Acute Perioperative Pain and Function in Total Knee Arthroplasty. J Arthroplasty. 2019. PMID: 30890391. doi:10.1016/j.arth.2019.02.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。